ThinkTrends agentic Document AI platform has been deployed at the U.S. Federal Health Agency as part of its new nationwide Adverse Event Monitoring System (AEMS), a major modernization initiative to improve how safety signals across drugs, vaccines, cosmetics, foods, medical devices, and other regulated products are monitored. The new platform replaces multiple fragmented reporting systems with a single real-time monitoring environment designed to process millions of adverse event reports each year across the agency’s product centers.
ThinkTrends agentic Document AI platform plays a critical role in the new system by handling unstructured safety data intake across centers. From emailed forms to scanned PDFs and handwritten reports, the system automates the extraction, normalization, and regulatory conversion of safety data. Using advanced AI, reports are classified, coded, and converted into structured outputs that accelerate the agency’s ability to analyze and act on emerging safety concerns.
The agency estimates approximately six to seven million adverse event reports are processed annually across multiple databases, with an annual cost of about 37 million dollars to maintain the legacy infrastructure. ThinkTrends agentic Document AI platform for pharmacovigilance intake played a key role in this modernization effort by automating the ingestion, classification, and normalization of large volumes of adverse event data across the agency’s multiple product centers. By consolidating these systems into a single AI-enabled platform, the new AEM is expected to save about 120 million dollars over the next five years while improving speed, accuracy, and accessibility. Early pilot use of the platform showed a 3,000 percent increase in user activity compared with previous reporting methods.
